Clinical Trial Update: Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates HPV vaccination in recipients of allogeneic stem cell transplantation and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Diffuse Large B-cell Lymphoma
• Human Papillomavirus Infection
• Myelodysplastic Syndrome

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Recipients of Allogeneic Stem Cell Transplantation, HPV (Human Papillomavirus)-Associated | Phase 2 | Status: RECRUITING